A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/30/2011	CA2498651C Nucleoside triphosphate diphosphohydrolase and uses thereof
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/30/2011	CA2425145C Methods of treatment using wisp polypeptides
08/30/2011	CA2405458C Herpes viruses for immune modulation
08/30/2011	CA2361534C Alpha-conotoxin peptides
08/30/2011	CA2331329C Diacylglycerol acyl transferase proteins
08/30/2011	CA2288962C Human monoclonal antibodies to epidermal growth factor receptor
08/30/2011	CA2283630C Ligand/lytic peptide compositions and methods of use
08/30/2011	CA2270531C A method for treating tension-type headache
08/30/2011	CA2251647C Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
08/25/2011	WO2011103591A1 Methods and compositions to treat hemorrhagic conditions of the brain
08/25/2011	WO2011103583A2 Methods and compositions related to anti-angiogenic peptides
08/25/2011	WO2011103575A1 Long-acting insulin analogue preparations in soluble and crystalline forms
08/25/2011	WO2011103471A1 Compositions and methods for the treatment of neurologic and psychiatric conditions
08/25/2011	WO2011103458A2 Compositions and methods for using and identifying antimicrobial agents
08/25/2011	WO2011103382A2 Compositions and methods for inducing angiogenesis
08/25/2011	WO2011103339A1 Use of pten-long leader sequence for transmembrane delivery of molecules
08/25/2011	WO2011103325A1 Methods for preparing human growth hormone
08/25/2011	WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer
08/25/2011	WO2011103215A1 Embedded chimeric peptide nucleic acids and use thereof
08/25/2011	WO2011103105A1 Fibronectin based scaffold domain proteins that bind il-23
08/25/2011	WO2011103076A1 Hsa-related compositions and methods of use
08/25/2011	WO2011103011A2 Gene fusion targeted therapy
08/25/2011	WO2011102999A2 Spink1 targeted therapy
08/25/2011	WO2011102901A1 Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphingosine-1-phosphate
08/25/2011	WO2011102847A1 Compositions and methods for treatment of parkinson's disease
08/25/2011	WO2011102574A1 Pharmaceutical composition for healing wounds, containing mic-1 gene or expression protein thereof
08/25/2011	WO2011101881A2 Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome
08/25/2011	WO2011101870A1 Fusion proteins for the treatment of multiple sclerosis and other autoimmune diseases
08/25/2011	WO2011101510A1 Cyclic peptides that inhibit cell growth
08/25/2011	WO2011101478A1 USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-β1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE
08/25/2011	WO2011101435A1 Activatable constructs
08/25/2011	WO2011101373A1 A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (prl)-growth hormone (gh)-placental lactogen (pl)-family protein
08/25/2011	WO2011101332A1 Compositions based on the fibronectin extracellular domain a for the treatment of melanoma
08/25/2011	WO2011101267A1 Conjugated fviii variants
08/25/2011	WO2011101242A1 Factor viii molecules with reduced vwf binding
08/25/2011	WO2011101173A1 Polypeptides
08/25/2011	WO2011100982A2 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS
08/25/2011	WO2011100841A1 Pd-1 modulation and uses thereof for modulating hiv replication
08/25/2011	WO2011053675A3 Improved neurturin molecules
08/25/2011	WO2011052883A3 Method for activating a natural killer cell by adjusting the expression of the socs2 gene
08/25/2011	WO2011041385A3 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/25/2011	WO2011032161A3 Vaccines directed to langerhans cells
08/25/2011	WO2011025996A9 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
08/25/2011	WO2011013912A3 Pharmaceutical composition for enhancing radiation therapy for cancer, and method for screening active material for enhancing radiation therapy for cancer
08/25/2011	WO2011008773A3 Mesenchymal stem cell differentiation
08/25/2011	WO2010115118A3 Methods for preparing and using multichaperone-antigen complexes
08/25/2011	WO2010087771A8 Compound and method for treatment of alzheimer's disease
08/25/2011	US20110209248 Novel sugar transporters
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110208168 Particle formulations for use in pharmaceutical compositions
08/25/2011	US20110207985 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207802 Glutamic acid decarboxylase (gad) based delivery system
08/25/2011	US20110207795 Smad7 inhibitor compositions and uses thereof
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207678 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207676 Glycosylation of Molecules
08/25/2011	US20110207675 Gene fusion targeted therapy
08/25/2011	US20110207674 Antitumoral compounds
08/25/2011	US20110207673 Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution
08/25/2011	US20110207672 Methods of treatment using a prodrug of an excitatory amino acid
08/25/2011	US20110207670 Compositions and methods of use for soluble thrombomodulin variants
08/25/2011	US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
08/25/2011	US20110207668 Binding proteins inhibiting the vegf-a receptor interaction
08/25/2011	US20110207667 Efficient expression of truncated human rnaset2 in e. coli
08/25/2011	US20110207666 Method of promoting bone growth with hyaluronic acid and growth factors
08/25/2011	US20110207665 Method of regulating proliferation and differentiation of keratinocyes
08/25/2011	US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207662 Composition for Long-Acting Peptide Analogs
08/25/2011	US20110207661 Benzylbenzene derivatives and methods of use
08/25/2011	US20110207660 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
08/25/2011	US20110207659 Oligosaccharide compositions and use thereof in the treatment of infection
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207657 Selectively Targeted Antimicrobial Peptides and the Use Thereof
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110207655 Cyclic depsipeptide compound and use thereof
08/25/2011	US20110207654 Peptide analogues
08/25/2011	US20110207653 Microparticle Encapsulated Thiol-Containing Polypeptides Together with a Redox Reagent
08/25/2011	US20110207174 Peptide-containing culture medium for culturing animal cell
08/25/2011	US20110206771 Encapsulated functional fine particle composition capable of spraying and preparation method thereof
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206759 Ccr7 ligand delivery and co-delivery in immunotherapy
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206752 Compositions for the treatment of pain and/or inflamation
08/25/2011	US20110206745 Octreotide implant having a release agent
08/25/2011	US20110206743 Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
08/25/2011	US20110206739 Compositions and methods for the preparation of nanoemulsions
08/25/2011	US20110206732 Albumin for treating cancer and a pharmaceutical composition comprising the combination of an anti-neoplastic agent and albumin
08/25/2011	US20110206723 Use of plant cell membrane for the treatment of obesity
08/25/2011	US20110206711 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine employing same
08/25/2011	US20110206706 Vaccine and method for treatment of neurodegenerative diseases
08/25/2011	US20110206690 Dimeric iap inhibitors
08/25/2011	US20110206684 Method of producing nutritional products from human milk tissue and compositions thereof
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206674 Yersinia SPP. Polypeptides and Methods of Use
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206661 Trimethoxyphenyl inhibitors of tyrosine kinase

1 ... 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 ... 3163